“…Aflatoxin B 1 (AFB 1 ) is a potent immunotoxicant and hepatocarcinogen in animals and probably in humans (Bondy and Pestka, 2000;Klein et al, 2000). The liver is the primary target organ, because AFB 1 requires metabolic activation to form the reputed carcinogenic species AFB 1 -8,9-epoxide (AFBO) (Mace et al, 1994(Mace et al, , 1997, but other organs are also affected by AFB 1 exposures (Ball and Coulombe, 1991;Ball et al, 1995;Coulombe et al, 1991;Imaoka et al, 1992;Kato et al, 1994;Kelly et al, 1997;Liu et al, 1990Liu et al, , 1993Liu and Massey, 1992). In human liver, CYPs 1A2 and 3A4 have been shown to be the principle enzymes responsible for AFB 1 activation (Ramsdell et al, 1991;Shimada and Guengerich, 1989) and have also been detected in human lung tissues and cultured lung cells (Mace et al, 1998;Van Vleet et al, 2001;Wei et al, 2001).…”